1. Introduction {#sec1-1}
===============

*Escherichia coli* is a clinically significant bacterium because they are the most common species recovered in the clinical laboratories and has been incriminated in human infectious diseases ([@ref23]. During the last few decades, *E. coli* have evolved toward antimicrobial resistance ([@ref27]; [@ref32]). The worldwide spread of *E. coli* strains with different multi-drug resistance (MDR) phenotypes make wide ranges of antimicrobials usefulness to treat most infections caused by this bacterium ([@ref8]; [@ref33]; [@ref2]; [@ref3]). Antimicrobial resistance has been reported in developed countries ([@ref34]; [@ref22]; [@ref31]). However, resistance to microbial agents is growing very fast in developing countries such as in Africa ([@ref28]), Asia (Hsueh et al., 2008; [@ref36]) and South America ([@ref7]). In Khartoum, capital of the Sudan, antimicrobial resistance patterns among clinical isolates were recorded as a major health problem ([@ref16]; [@ref20]). In Aseer region, south west of Saudi Arabia, previous studies undertaken to determine the prevalence of various bacterial pathogens causing infections and their *in vitro* antimicrobial susceptibility profile ([@ref8]; [@ref17]). In a year 2001, a study was conducted in Abha Maternity Hospital, a teaching hospital in Aseer, south-west region of Saudi Arabia, about 30 different resistance patterns were shown by either the hospital or community isolates ([@ref8]). Increasing of international travelling from country to another have potential role in the spread and dissemination of resistant bacteria ([@ref9]; [@ref27]). However, comparative study of antimicrobial resistance of bacterial pathogens between countries and different geographical regions may be helpful in the evaluation of resistance problem ([@ref9]). This study aimed to compare between antimicrobial resistance patterns of clinical *E. coli* isolates from patients at hospitals in Khartoum state, Sudan to those collected from hospitals in Aseer region, Saudi Arabia.

2. Methods {#sec1-2}
==========

2.1 Study Design and Settings {#sec2-1}
-----------------------------

This was a descriptive comparative study conducted during the period between May 2010 and August 2011. A total of 402 *E. coli* were isolated from various clinical specimens of patients of all age groups at six hospitals in Khartoum State, Sudan and two hospitals in Aseer region, southwest of Saudi Arabia. In Sudan, full details of *E. coli* isolates and participating hospitals have been described in our previous study ([@ref20]). While in Saudi Arabia, *E. coli* were collected from two hospitals including Aseer Central Hospital and Abha Maternity Hospital. The related hospitals in both countries were referral and educational hospitals, including different specialties and therefore serving various patient groups and covering the most population of different areas.

The study was laboratory based study and did not involve any intervention concerning the patients directly. All databases which included, specimen source and patient sex, age and setting were carefully recorded from laboratory request form. Therefore, ethical approval form did not obtained as per study guidelines.

2.2 Bacterial Isolates {#sec2-2}
----------------------

The microbiology laboratory of each hospital undergoes the routine processing of the various clinical specimens of patients. Isolation and identification of pathogenic *E. coli* followed standard conventional procedures ([@ref11]; [@ref15]).

2.3 Antimicrobial Susceptibility Testing {#sec2-3}
----------------------------------------

Antimicrobial susceptibility testing of *E. coli* isolates were performed by the Kirby-Bauer disk diffusion assay on Mueller-Hinton agar medium (Oxoid, Basingstoke, England) as recommended by Clinical Laboratory Standard Institute (CLSI, 2011), against 15 antimicrobial agents from different categories including: amikacin (30 μg), amoxicillin (10 μg), amoxicillin-clavulanic acid (30 μg), ceftazidime (30 μg), ceftriaxone (30 μg) cefuroxime (30 μg), chloramphenicol (30 μg), ciprofloxacin (5 μg), gentamicin (10 μg), nalidixic acid (30 μg), nitrofurantoin (50 μg), ofloxacin (5 μg), tetracycline (30 μg), tobramicin (10 μg) and trimethoprim- sulfamethoxazole (25 μg) (Oxoid, Basingstoke, England). *E. coli* isolate was considered non-susceptible to an antimicrobial agent when it tested resistant, intermediate or non-susceptible when using clinical breakpoints as interpretive criteria, provided by the CLSI, (2011). MDR patterns of *E. coli* isolates were defined as non-susceptibility to at least one agent in three or more antimicrobial categories ([@ref25]).

2.4 Statistical Analysis {#sec2-4}
------------------------

Collected data were analyzed using Statistical Package for Social Sciences (SPSS; Version 10) software. Comparisons of antimicrobial resistance rate of isolates from both countries were done in term of setting, sex and age. The proportions were compared using the Chi-square test. A p-value of less than 0.05 was considered as statistically significant.

3. Results {#sec1-3}
==========

3.1 Characterizations of E. coli Isolates {#sec2-5}
-----------------------------------------

A total of 402 *E. coli* isolates (232 from Khartoum state, Sudan and 170 from Aseer region, Saudi Arabia) were examined for antimicrobial susceptibility testing using double-disk diffusion method against 15 antimicrobial agents from different categories. Out of the 402 *E. coli* isolates tested for their antimicrobial susceptibility, 334 isolates were characterized as MDR strains from the two geographical regions. The majority of MDR *E. coli* were recovered from specimens of urine (n = 220) followed by wounds (n = 59) and vaginal swabs (n = 20) with low isolation rates from other specimens ([Table 1](#T1){ref-type="table"}).

###### 

Distribution of MDR *E. coli* (n = 334) collected from Khartoum state, Sudan and Aseer region, Saudi Arabia in relation to specimen types

  Specimen type              Khartoum state, (Sudan) (n=214)   Aseer region (Saudi Arabia) (n=120)
  -------------------------- --------------------------------- -------------------------------------
                             No. of MDR *E. coli* (%)          No. of MDR *E. coli* (%)
  Urine (n =220)             135 (63.1)                        85 (70.8)
  Wound pus (n =59)          51 (23.8)                         8 (6.7)
  Vaginal swab (n =20)       7 (3.3)                           13 (10.8)
  Blood culture (n = 7)      5 (2.3)                           2 (1.7)
  Semen Fluid (n = 3)        3 (1.4)                           0.0 (0.0)
  Stool (n =11)              2 (0.9)                           9 (7.5)
  Ear swab (n =11)           8 (3.7)                           3 (2.5)
  Other body fluids (n =3)   3 (1.4)                           0.0 (0.0)

Out of 232 *E. coli* strains collected from patients in Khartoum state, Sudan, 214 (92.2%) were found to be MDR *E. coli*. These 214 MDR *E. coli* isolates were obtained from all age groups: 125 (58.4%) were from females and 89 (41.6%) were from males. Of these 214 MDR isolates, 168 (78.5%) were obtained from adult patients, whereas 46 (21.5%) from children.

Of the 170 *E. coli* strains collected from hospitals in Aseer region, Saudi Arabia, MDR *E. coli* represented 120 (70.6%) of total isolates. These 120 isolates were obtained from females (n = 77) and males (n = 43). Eighty seven (72.5%) of the 120 isolates were from adults, whereas 33 (27.5%) were from children patients.

3.2 Frequency of MDR Patterns of E. coli {#sec2-6}
----------------------------------------

The occurrence of MDR patterns was found to be significantly higher among *E. coli* sourced from Khartoum state, Sudan than that from Aseer region, Saudi Arabia isolates \[92.2% (214/232) vs. 70.6% (120/170)\] (p = 0.000).

[Table 2](#T2){ref-type="table"} summarized the resistance patterns of *E. coli* recovered from clinical specimens of patients in Kartoum state, Sudan and Aseer region, Saudi Arabia. The resistance rates among the strains from both countries were recorded as follows (Sudan and Saudi Arabia): High to moderate resistance rates of isolates were observed in amoxicillin (97.7% and 94.2%), cefuroxime (92.5% and 35.8%), trimethoprim-sulfamethoxazole (88.3% and 82.5%), tetracycline (77.1% and 74.2%), nalidixic acid (72% and 57.5%) ceftriaxone (64%). ciprofloxacin (58.4% and 40%), ofloxacin (55.1% and 38.3%), amoxicillin-clavulanate (51.4% and 70%). Low resistance rates of isolates were observed to ceftazidime (35% and 20%), gentamicin (35% and 17.5%), nitrofurantoin (22.4% and 11.7%), chloramphenicol (18.2% and 18.3%), and tobramicin (18.2% and 29.2%). Resistance to amikacin was uncommon (1.9% and 5%).

###### 

Antimicrobial resistance patterns of *E. coli* strains collected from patients in Khartoum state, Sudan and Aseer region, Saudi Arabia

  Antimicrobial agent             Khartoum state (n = 214)   Aseer region (n = 120)   P. value
  ------------------------------- -------------------------- ------------------------ ----------
  Amikacin                        1.9                        5.0                      0.108
  Amoxicillin                     97.7                       96.7                     0.591
  Amoxicillin-clavulanic acid     51.4                       70                       0.001
  Ceftazidime                     35                         20                       0.004
  Ceftriaxone                     64                         31.7                     \< 0.001
  Cefuroxime                      92.5                       35.8                     \< 0.001
  Chloramphenicol                 18.2                       18.3                     0.980
  Ciprofloxacin                   58.4                       40                       0.001
  Gentamicin                      35                         17.5                     0.001
  Nalidixic acid                  72                         57.5                     0.007
  Nitrofurantoin                  22.4                       11.7                     0.015
  Ofloxacin                       55.1                       38.3                     0.003
  Tetracycline                    77.1                       74.2                     0.548
  Tobramicin                      18.2                       29.2                     0.021
  Trimethoprim-sulfamethoxazole   88.3                       82.5                     0.140

As shown in [Table 2](#T2){ref-type="table"}, there were significant differences (p \< 0.05) of antimicrobial resistance rates of *E. coli* isolates collected from Khartoum state, when compared to those from Aseer region. Strains from Khartoum state were more resistant to ceftazidime, ceftriaxone, cefuroxime, ciprofloxacin, gentamicin, nalidixic acid, nitrofurantoin and ofloxacin, whereas isolates fromAseer region were more resistant to amoxicillin-clavulanic acid and tobramicin. In general, Sudan sourced strains were more resistant to antimicrobial agents than those from Saudi Arabia.

3.3 Comparison of Antimicrobial Resistance in Relation to Patient's Gender {#sec2-7}
--------------------------------------------------------------------------

[Figure 1](#F1){ref-type="fig"} shows the rates of resistance of *E. coli* strains recovered from male patients in Khartoum state, Sudan and Aseer region, Saudi Arabia. Higher percentage of resistance was reported among isolates from males in Khartoum state than those from Aseer region for ceftriaxone (p \< 0.001), cefuroxime (p \< 0.001), gentamicin (p = 0.002), nitrofurantoin (p = 0.037), trimethoprim-sulfamethoxazole (p = 0.001). In contrast, higher resistance rates among isolates from Aseer region were observed for amoxicillin-clavulanic acid (p \< 0.001) and tobramicin (p = 0.003).

![Comparison of resistance pattern of *E. coli* isolated from male patients in Khartoum state to those from Aseer region](GJHS-6-126-g001){#F1}

When comparing the resistance rates of *E. coli* isolates recovered from female patients in Khartoum state to those fromAseer region ([Figure 2](#F2){ref-type="fig"}), the incidence of cephalosporins and quinolones resistance were higher among females from Khartoum state than those from females in Aseer region, whereas no statistical differences were observed in the remaining tested antimicrobial agents.

![Comparison of resistance pattern of *E. coli* isolated from female patients in Khartoum state to those from Aseer region](GJHS-6-126-g002){#F2}

3.4 Characterization of MDR Phenotypes of E. coli Isolates {#sec2-8}
----------------------------------------------------------

[Figure 3](#F3){ref-type="fig"} shows the resistant phenotypes of *E. coli* isolates collected from Khartoum state, Sudan and Aseer region, Saudi Arabia according to the given number (n = 3 to 15) of antimicrobial drugs. Among the isolates collected from Khartoum state, Sudan the most prevalent MDR phenotypes were to 7 (15.9%), followed by 8 (11.7%) of tested antimicrobial agents. While among the strains originated from Saudi Arabia, the most frequent MDR patterns were to 3 (20.8%) followed by 5 (13.3%) and 4 (15.8%) of antimicrobial agents.

![The percentage of *E. coli* isolates recovered from hospitals in Khartoum state, Sudan and Aseer region, Saudi Arabia showing different MDR phenotypes to a given number (3 to 15) of antimicrobial drugs](GJHS-6-126-g003){#F3}

The most frequent resistance profiles among Sudan strains were: AML-AMC-CXM-CRO-CAZ- CIP-OFX-NA-SXT-TE (8 strains) followed by AML-CXM-CRO-CAZ-CIP-OFX-NA-SXT-TE and AML-CXM-SXT-TE (7 strains), AML-CXM-CRO-CAZ-CIP-OFX-NA-SXT-TE-GN-TOB and AML-CXM- CRO-CAZ-F-SXT-C (6 strains each). Among Saudi Arabia strains, the predominant resistance profiles were: AML-SXT-TE (12 strains), AML-AMC-CXM-CRO-CAZ-CIP-OFX-NA-SXT-TE-TOB (10 strains), AML-AMC -SXT-TE (8 strains) and AML-AMC-NA-SXT-TE (6 strains).

4. Discussion {#sec1-4}
=============

This study was focused on the antimicrobial resistance patterns of *E. coli* isolates recovered from two different unrelated geographical areas of Khartoum state in Sudan and Aseer region in Saudi Arabia. Antimicrobial resistance rates vary among regions and countries, with increasing rates in the many parts of the world ([@ref9]; [@ref7]; [@ref28]; Hsueh et al., 2008; [@ref36]; [@ref20]).In certain countries, the spread of resistance pathogens is mainly due to inappropriate use of antibiotics ([@ref27]; [@ref2]; [@ref3]; [@ref28]).Therefore, the availability of antibiotics without prescriptions, insufficient education of the medical profession about drugs, non-availability of guidelines for therapy and shortage in quality control measures are contributing in development and emerging of antimicrobial resistance ([@ref19]; [@ref6]; [@ref5]). In the present study, the MDR patterns of *E. coli* isolates from the Khartoum state hospitals, Sudan was found to be increasing (92.2%) when comparing to a survey done in Sudan in the year 2000 in which MDR were recorded as 58% ([@ref1]). In a recent study in the Sudan, *E. coli* isolates from urinary tract infections with its multi resistance towards antimicrobials has been documented ([@ref16]).Whilst MDR rates of *E. coli* in Aseer region, Saudi Arabia were recorded as 70.6%. This percentage was still of higher levels compared to previous study carried out in the same regions by [@ref8]. These authors reported MDR rates among clinical *Enterobacteriaceae* isolates as more than 74 % in the year 2000. Moreover, our findings were much higher than 39% found as MDR *E. coli* in another region of Saudi Arabia ([@ref2]). These findings indicate that antimicrobial resistance pattern among clinical isolates is emerging in both geographical areas and could complicate the treatment of infections lead to serious health problem. The high rates of MDR patterns among the isolates in this study might be due to misuse and unnecessary prescription of antimicrobial drugs in both countries. In this study, we found that urine is a principle source of MDR isolates from both regions. In this study, we found that urine is a principle source of MDR isolates from both studied regions. As described by others ([@ref35]), the existence of marked differences in the susceptibility to several antimicrobial agents depending on the site of the isolates. On the other hand, resistance patterns of isolates from abscesses, bloodstream, exudate, fluids and wounds were not different from each other or from urine have been previously reported ([@ref10]). In our study, a possible sample bias where urine sampling is most common that could be attributed the high MDR isolates in urine samples.

The present study determined high resistance levels (72.2%-98.8%) among *E. coli* isolated from the both countries for the first-line oral antimicrobial agents such as amoxicillin, trimethoprim-sulfamethoxazole, tetracycline, nalidixic acid and amoxicillin-clavulanic acid. Similar rates of resistance have been previously reported in Sudan ([@ref1]), Saudi Arabia ([@ref8]; [@ref2]), other developing countries ([@ref29]; [@ref3]) and developed countries ([@ref34]; [@ref32]; [@ref10]). The high rates of resistance to these commonly used oral antimicrobials makes these agents useless for the empirical treatment of bacterial infection ([@ref7]; [@ref10]; [@ref26]).

Fluoroquinolones are effective antimicrobial agents used for the treatment of a wide variety of bacterial infections ([@ref14]). High rates of *E. coli* isolates non-susceptible to fluoroquinolones have been reported in many countries as in Thailand (\>50%), China (≥70%) and India (\>80%) ([@ref18]). In the present study, isolates from Sudanese patients revealed relatively high resistance rates (58.4%) to ciprofloxacin, whereas 40% of Saudi Arabia sourced strains were ciprofloxacin resistant. These proportions were higher than previous finding in Saudi Arabia by Al-Tawfig, (2006), who reported ciprofloxacin resistant rates at 33%, among *E. coli* isolates from nosocomial infections. [@ref24] have determined that 26.6 % of *E. coli* isolates were resistant to ciprofloxacin from Korean patients with acute uncomplicated cystitis. Another report from Ghana estimated that 12 to 18% of fecal *E. coli* isolates are quinolones resistant ([@ref26]). The high rates of resistant in our study have been hypothesized to be related to the inappropriate use of fluoroquinolones ([@ref24]). Also, prolonged use of low dose of fluoroquinolones has been shown to be the most significant risk factor for acquisition of resistance as previously described by [@ref12].

In this study, higher resistance rates were observed among *E. coli* strains collected from Sudan than Saudi Arabia for ceftriaxone (64% vs. 31.7%) (p\< 0.001) and ceftazidime (35% vs. 20%) (p = 0.004). In a study carried out at two hospitals in Makka city, Saudi Arabia, resistance rates of *E. coli* isolates were recorded as 36.2 % for cefuroxime, 24.6 % for ceftazidime and 18.3% for ceftriaxone ([@ref4]). Obviously our findings reflected high resistance rate for cefuroxime (92.5%) among Sudan sourced isolates. The high percentage of resistance to cephalosporins notably to cefuroxime in Sudan hospitals is of great concern, since it was found to be much higher than those reported in other parts of the world ([@ref30]; [@ref32]). In a13-years hospital based study the rise in cephalosporins resistant *E. coli* was documented due to increased consumption of these drugs ([@ref19]).

This study indicated that there were higher significant differences in resistance levels of *E. coli* strains collected from Khartoum state, Sudan comparable to Aseer region, Saudi Arabia in term of gender and age of the patients. Mostly, isolates from different studied population groups in Sudan were more likely to have higher rates of resistance to antimicrobials. Males in Sudan were more resistant than those from Saudi Arabia to cefuroxime (95.5% vs. 39.5%), trimethoprim-sulfamethoxazole (94.4% vs. 74.4%) and gentamicin (38.2% vs. 11.6%) whereas, higher resistance to amoxicillin-clavulanic acid and tobramicin were observed in Saudi Arabia sourced strains (90.7% and 46.5%, respectively) than that from Sudan (48.3% and 21.3%, respectively). These figures are indication of variations in resistance patterns in both countries with relatively higher rates in Sudan. The possible explanation is that this could be due to differences in prescribing patterns, types and quality of antimicrobial agents, as well as availability of drugs. Or perhaps due to better control strategies in the use of antimicrobial drugs, monitoring of resistance levels and updating prescribing policies in Saudi hospitals than in Sudan. [@ref1] have addressed a local problem in the Sudan, where it appears that there is a higher prevalence of antibiotic resistance compared to other countries. [@ref16] proposed that the inappropriate use of antimicrobial in low income countries is perhaps due to the lack of adequate knowledge about drugs and non-availability or non-accessibility of guidelines for therapy. Another study has reported an emerging cause of resistance in Sudan, due to increasing inappropriate and excessive prescribing patterns of antibiotics in health centers ([@ref6]). Furthermore, self medication and poor quality of available antibiotics has been noted in Sudan ([@ref5]).

The common MDR phenotypes in our isolates were between amoxicillin/trimethoprim-sulfamethoxazole/cefuroxime/tetracycline/or nalidixic acid/amoxicillin-clavulanic acid. In the early study of antimicrobial resistance in bacterial isolates from patients with diarrhea and urinary tract infection in the Sudan, the most common MDR profile of isolates was reported to ampicillin, amoxicillin, tetracycline, trimethoprim-sulfamethoxazole, sulfonamide, and chloramphenicol ([@ref1]). Likewise, these resistant patterns were also noted by others ([@ref8]; [@ref7]). These findings may not be surprising, since antimicrobial agents are commonly used widely by populations. However, bacteria can develop MDR patterns through different genetic mechanisms ([@ref36]; [@ref21]).

The study concluded that antimicrobial resistance of pathogenic *E. coli* isolates is alarming and emerging in the both regions of Khartoum state, Sudan as well as in Aseer, Saudi Arabia, with different kinds of resistance patterns. Such high rates of resistance among isolates might be due to misuse and unnecessary prescription of antimicrobial drugs in both countries. Continuous monitoring and updating of antimicrobial resistance profile data as well as hospital policy for restriction and prudent use of antimicrobial drugs can reduce the spread of MDR strains. Antimicrobial resistance varied between settings, population and countries therefore, local and international surveillance programs in each region and setting are required.
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